- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Clinical Study of Levofloxacin (LVFX) 400 mg Orally in Two Divided Portions for Acute Exacerbation of Chronic Otitis Media and Chronic Sinusitis
-
- Kimura Yo
- Yamagata prefectural hospital
-
- Furuse Hidekazu
- Yamagata prefectural hospital
-
- Okazaki Shin-ichi
- Yamagata prefectural hospital
-
- Kiren Teruo
- Kiren ENT clinic
-
- Watanabe Tomoo
- Yamagata university school of medicine
-
- Isii Ken-iti
- Yamagata prefectural hospital
Bibliographic Information
- Other Title
-
- 中耳炎および副鼻腔炎に対するLVFX(クラビット)の効果―1日400mg分2投与の有用性―
- ヤクブツ チュウジエン オヨビ フクビクウエン ニ タイスル LVFX クラビット ノ コウカ 1ニチ 400mg ブン 2 トウヨ ノ ユウヨウセイ
- 1日400mg分2投与の有用性
Search this article
Description
Twenty-six adult cases of acute exacerbation of chronic otitis media (COM) and twenty cases of acute exacerbation of chronic sinusitis (CS) were treated by Levofloxacin (LVFX) 400mg a day in two divided portions. The clinical efficacy rates were 84.6% for COM and 85% for CS. Bacteriolgical therapeutic failures in treatment were observed in four COM and three CS patients. Adverse response and abnormal laboratory findings were not observed. LVFX was more effective when given at 400mg a day in two divided portions.
Journal
-
- Practica Oto-Rhino-Laryngologica
-
Practica Oto-Rhino-Laryngologica 99 (2), 151-156, 2006
The Society of Practical Otolaryngology
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679241680512
-
- NII Article ID
- 130001816961
- 10017161708
-
- NII Book ID
- AN00107089
-
- ISSN
- 18844545
- 00326313
-
- NDL BIB ID
- 7817293
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed